← Leaderboards
Stephen Mark Rao
Cleveland Clinic Lerner Com-Cwru
$16,514,385
Attributed
$24,979,864
Total exposure
18
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,979,864 · 18
By mechanism
R01$21,350,517 · 3
U01$1,241,828 · 1
RC1$968,509 · 1
M01$746,782 · 11
R56$410,502 · 1
P01$261,726 · 1
Top collaborators
- Bruce T Lamb7 shared
- Jay L Alberts6 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Jay L Alberts$15,319,411
- Bruce D Trapp$26,095,443
- Srinivasan Dasarathy$21,059,442
- Ying Ni$927,474
- Matthew A Plow$358,341
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposFunctional Magnetic Resonance ImagingCognitionClinical ResearchParticipantPerformanceBrainCognitiveDiagnosisMemoryMagnetic Resonance ImagingS DiseaseHuman SubjectImageExhibitsImpaired CognitionAllelesPersonsNeuropsychological TestsElderlyDisease ProgressionS Disease RiskLongitudinal StudiesHippocampus (Brain)
Grant awards (56)
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for AlzheimerÂs Disease$1,476,501
R01 · FY2025 · AG · contact PI
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for AlzheimerÂs Disease$1,264,973
R01 · FY2024 · AG · contact PI
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimer's Disease$376,774
R01 · FY2024 · AG · contact PI
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for AlzheimerÂs Disease$1,544,290
R01 · FY2023 · AG · contact PI
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for AlzheimerÂs Disease$1,423,624
R01 · FY2022 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,533,181
R01 · FY2021 · AG · contact PI
CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for AlzheimerÂs Disease$1,303,339
R01 · FY2021 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$410,013
R01 · FY2021 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,817,926
R01 · FY2020 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$2,026,775
R01 · FY2019 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,859,251
R01 · FY2018 · AG · contact PI
IMMUNE-AD Administrative Supplement To Support a Recruitment Specialist and MRI Pulse Sequence Programming$211,600
R01 · FY2018 · AG · contact PI
Immune Mechanisms Underlying the Neuroprotective Effects of Physical Activity in Human and Mouse Models of Genetic Risk for Alzheimers Disease$1,682,711
R01 · FY2017 · AG · contact PI
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease$374,592
R01 · FY2015 · AG · contact PI
Functional Connectivity in Premanifest Huntington's Disease$376,781
U01 · FY2014 · NS · contact PI
Functional Connectivity in Premanifest Huntington's Disease$400,917
U01 · FY2013 · NS · contact PI
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease$364,433
R01 · FY2013 · AG · contact PI
Functional Connectivity in Premanifest Huntington's Disease$464,130
U01 · FY2012 · NS · contact PI
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease$385,116
R01 · FY2012 · AG · contact PI
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease$384,601
R01 · FY2011 · AG · contact PI
Neural Effects of Exercise, Cognitive, or Combined Training in AD At-Risk Elders$468,701
RC1 · FY2010 · AG · contact PI
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease$431,234
R01 · FY2010 · AG · contact PI
Neural Effects of Exercise, Cognitive, or Combined Training in AD At-Risk Elders$499,808
RC1 · FY2009 · AG · contact PI
fMRI as an Imaging Biomarker for Preclinical Alzheimer's Disease$410,502
R56 · FY2009 · AG · contact PI
FRMI OF THE PERSON IDENTITY NETWORK: AGING AND APOE$280,793
R01 · FY2007 · AG · contact PI
FRMI OF THE PERSON IDENTITY NETWORK: AGING AND APOE$291,043
R01 · FY2006 · AG · contact PI
FMRI OF THE PERSON IDENTITY NETWORK: AGING AND APOE$128,049
M01 · FY2006 · RR · contact PI
FMRI EVALUATION OF PARKINSON'S DISEASE$43,756
M01 · FY2006 · RR · contact PI
FUNCTIONAL MRI OF COGNITIVE PROCESSES$28,313
M01 · FY2006 · RR · contact PI
FUNCTIONAL NEUROANATOMY OF HUMAN FEAR CONDITIONING$2,573
M01 · FY2006 · RR · contact PI
FRMI OF THE PERSON IDENTITY NETWORK: AGING AND APOE$299,895
R01 · FY2005 · AG
FMRI OF THE PERSON IDENTITY NETWORK: AGING AND APOE$41,699
M01 · FY2005 · RR
FUNCTIONAL MRI OF COGNITIVE PROCESSES$30,992
M01 · FY2005 · RR
FUNCTIONAL NEUROANATOMY OF HUMAN FEAR CONDITIONING$27,611
M01 · FY2005 · RR
FUNCTIONAL MRI OF TEMPORAL INFORMATION PROCESSING$6,199
M01 · FY2005 · RR
COGNITION AND METHYLPHENIDATE: FMRI STUDY OF ADHD ADULTS$5,634
M01 · FY2005 · RR
FMRI &COGNITION IN PRE-SYMPTOMATIC HUNTINGTON'S DISEASE$2,818
M01 · FY2005 · RR
FMRI EVALUATION OF PARKINSON'S DISEASE$1,128
M01 · FY2005 · RR
FRMI OF THE PERSON IDENTITY NETWORK: AGING AND APOE$301,689
R01 · FY2004 · AG
Functional MRI of Cognitive Processes$82,748
M01 · FY2004 · RR
Functional Neuroanatomy of Human Fear Conditioning$56,179
M01 · FY2004 · RR
Cognition and Methylphenidate: fMRI Study of ADHD Adults$34,921
M01 · FY2004 · RR
Functional MRI of Temporal Information Processing$6,074
M01 · FY2004 · RR
FRMI OF THE PERSON IDENTITY NETWORK: AGING AND APOE$322,830
R01 · FY2003 · AG
COGNITION AND METHYLPHENIDATE--FMRI STUDY OF ADHD ADULTS$340,756
R01 · FY2002 · MH
FUNCTIONAL MRI OF TEMPORAL INFORMATION PROCESSING$0
P01 · FY2002 · MH
COGNITION AND METHYLPHENIDATE--FMRI STUDY OF ADHD ADULTS$331,255
R01 · FY2001 · MH
FUNCTIONAL MR IMAGING OF COGNITIVE PROCESSES$248,088
M01 · FY2001 · RR
COGNITION AND METHYLPHENIDATE--FMRI STUDY OF ADHD ADULTS$26,696
R01 · FY2001 · MH
FUNCTIONAL MRI OF TEMPORAL INFORMATION PROCESSING$0
P01 · FY2001 · MH
COGNITION AND METHYLPHENIDATE--FMRI STUDY OF ADHD ADULTS$284,626
R01 · FY2000 · MH
FUNCTIONAL MRI OF TEMPORAL INFORMATION PROCESSING$261,726
P01 · FY2000 · MH
FUNCTIONAL MR IMAGING OF COGNITIVE PROCESSES$0
M01 · FY2000 · RR
COGNITION AND METHYLPHENIDATE--FMRI STUDY OF ADHD ADULTS$0
M01 · FY2000 · RR
COGNITION AND METHYLPHENIDATE--FMRI STUDY OF ADHD ADULTS$0
M01 · FY2000 · RR
FUNCTIONAL MR IMAGING OF COGNITIVE PROCESSES$0
M01 · FY2000 · RR